Wentao Yue
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 8
- Obstetrics and Gynecology top 10%
- Pregnancy and preeclampsia studies 15
- Gestational Diabetes Research and Management 10
- Oncology top 10%
- Cancer-related Molecular Pathways 11
-
- Microfluidic and Bio-sensing Technologies 9
-
- Ferroptosis and cancer prognosis 9
- Lung Cancer Treatments and Mutations 8
-
- Birth, Development, and Health 8
- Co-authors
- Xiaoting ZhaoLína ZhangMeng GuJian ChenMei JiangYang ZhaoQi ChenChenghong Yin
- Journals
- SHILAP Revista de lepidopterología (5 papers)PLoS ONE (1 paper)The Science of The Total Environment (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wentao Yue
106 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 189
- Obstetrics and Gynecology 89
- Oncology 305
- Molecular Biology 549
- Immunology 147
Countries citing papers authored by Wentao Yue
This map shows the geographic impact of Wentao Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wentao Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wentao Yue more than expected).
Fields of papers citing papers by Wentao Yue
This network shows the impact of papers produced by Wentao Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wentao Yue. The network helps show where Wentao Yue may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wentao Yue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 0 | |
| 14 | 2022 | 47 | |
| 15 | 2020 | 1 | |
| 16 | 2020 | 22 | |
| 17 | 2019 | 6 | |
| 18 | Drug response to PD-1/PD-L1 blockade: based on biomarkers | 2018 | 2 |
| 19 | 2018 | 13 | |
| 20 | 2017 | 12 |
About Wentao Yue
Wentao Yue is a scholar working on Obstetrics and Gynecology, Cancer Research and Oncology, having authored 114 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pregnancy and preeclampsia studies (15 papers), Cancer-related Molecular Pathways (11 papers), Gestational Diabetes Research and Management (10 papers), Microfluidic and Bio-sensing Technologies (9 papers), Ferroptosis and cancer prognosis (9 papers), Birth, Development, and Health (8 papers), Cancer-related molecular mechanisms research (8 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Cancer Research (189 citations), Obstetrics and Gynecology (89 citations) and Oncology (305 citations). Wentao Yue has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaoting Zhao, Lína Zhang, Meng Gu, Jian Chen, Mei Jiang, Yang Zhao, Qi Chen, Chenghong Yin, Hongyu Zhao and Rong Long. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.